See All Slides - tctmd.com

Slides

Presentation THT Abstracts 2024

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Presenter: Jacob Abraham

March 05, 2024

Presentation THT Abstracts 2024

Clinical Outcomes and the Impact of SCAI Stage among ProtekDuo Right Ventricular Assist Device Recipients with Cardiogenic Shock: A Report from the Cardiogenic Shock Working Group

Presenter: Kevin John

March 05, 2024

Presentation THT Abstracts 2024

Duration of Intra-Aortic Entrainment Pump Therapy and Clinical Outcomes in Acute Decompensated Heart Failure and Cardiorenal Syndrome

Presenter: Matteo Fabbri

March 05, 2024

Presentation THT Abstracts 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Presentation THT Abstracts 2024

Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF)

Presenter: Alexandra Steverson

March 05, 2024

Presentation THT Abstracts 2024

Percutaneous VA-ECMO during TAVI in Patients with Cardiogenic Shock and Severely Depressed Left Ventricular Function

Presenter: Eduardo Arias

March 05, 2024

Presentation THT Abstracts 2024

Predictors of Acute Limb Ischemia in Cardiogenic Shock patients on Mechanical Circulatory Support

Presenter: Kevin John

March 05, 2024

Presentation THT Abstracts 2024

Right Ventricular Preservation with Implant-Free Interatrial Shunt

Presenter: Saibal Kar

March 05, 2024

Presentation THT Abstracts 2024

Central and Peripheral Determinants of Exercise with the HeartMate 3TM LVAD

Presenter: David Golombeck

March 05, 2024

Presentation THT Abstracts 2024

High Frequency Virtual Cardiology Intervention (HF-VCI) in implementing Heart Failure Guideline-Directed Medical Therapy (HF-GDMT)

Presenter: Daniel Bensimhon

March 05, 2024

Advertisement

Slides

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Clinical Outcomes and the Impact of SCAI Stage among ProtekDuo Right Ventricular Assist Device Recipients with Cardiogenic Shock: A Report from the Cardiogenic Shock Working Group

Duration of Intra-Aortic Entrainment Pump Therapy and Clinical Outcomes in Acute Decompensated Heart Failure and Cardiorenal Syndrome

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF)

Percutaneous VA-ECMO during TAVI in Patients with Cardiogenic Shock and Severely Depressed Left Ventricular Function

Predictors of Acute Limb Ischemia in Cardiogenic Shock patients on Mechanical Circulatory Support

Right Ventricular Preservation with Implant-Free Interatrial Shunt

Central and Peripheral Determinants of Exercise with the HeartMate 3TM LVAD

High Frequency Virtual Cardiology Intervention (HF-VCI) in implementing Heart Failure Guideline-Directed Medical Therapy (HF-GDMT)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content